AbbVie Inc (ABBV)
167.80
-1.74
(-1.03%)
USD |
NYSE |
Apr 24, 16:00
167.00
-0.80
(-0.48%)
After-Hours: 20:00
AbbVie Cash from Investing (Quarterly): -800.00M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -800.00M |
| September 30, 2023 | -369.00M |
| June 30, 2023 | -341.00M |
| March 31, 2023 | -499.00M |
| December 31, 2022 | -448.00M |
| September 30, 2022 | 1.286B |
| June 30, 2022 | 130.00M |
| March 31, 2022 | -1.591B |
| December 31, 2021 | -1.145B |
| September 30, 2021 | -615.00M |
| June 30, 2021 | -242.00M |
| March 31, 2021 | -342.00M |
| December 31, 2020 | -627.00M |
| September 30, 2020 | -1.149B |
| June 30, 2020 | -35.65B |
| March 31, 2020 | -129.00M |
| December 31, 2019 | -615.00M |
| September 30, 2019 | 1.378B |
| June 30, 2019 | -140.00M |
| March 31, 2019 | -27.00M |
| December 31, 2018 | -283.00M |
| September 30, 2018 | -963.00M |
| June 30, 2018 | 687.00M |
| March 31, 2018 | -447.00M |
| December 31, 2017 | 201.00M |
| Date | Value |
|---|---|
| September 30, 2017 | -109.00M |
| June 30, 2017 | 318.00M |
| March 31, 2017 | -684.00M |
| December 31, 2016 | -119.00M |
| September 30, 2016 | -199.00M |
| June 30, 2016 | -4.298B |
| March 31, 2016 | -1.458B |
| December 31, 2015 | -297.00M |
| September 30, 2015 | 745.00M |
| June 30, 2015 | -12.51B |
| March 31, 2015 | -873.00M |
| December 31, 2014 | 2.514B |
| September 30, 2014 | -2.284B |
| June 30, 2014 | -359.00M |
| March 31, 2014 | -797.00M |
| December 31, 2013 | 123.00M |
| September 30, 2013 | -964.00M |
| June 30, 2013 | 233.00M |
| March 31, 2013 | 1.487B |
| December 31, 2012 | -206.00M |
| September 30, 2012 | -1.806B |
| June 30, 2012 | -202.00M |
| March 31, 2012 | -204.00M |
| December 31, 2011 | 508.92M |
| September 30, 2011 | 474.10M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-35.65B
Minimum
Jun 2020
1.378B
Maximum
Sep 2019
-2.206B
Average
-448.00M
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -27.09B |
| Immunogen Inc (DELISTED) | -1.354M |
| Johnson & Johnson | -1.202B |
| Eli Lilly and Co | -2.924B |
| Merck & Co Inc | 53.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 4.753B |
| Cash from Financing (Quarterly) | -4.449B |
| Free Cash Flow | 22.06B |
| Free Cash Flow Per Share (Quarterly) | 2.561 |
| Free Cash Flow to Equity (Quarterly) | 5.909B |
| Free Cash Flow to Firm (Quarterly) | 4.805B |
| Free Cash Flow Yield | 7.41% |